Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 22720164)

1.

Solubilization and humanization of paraoxonase-1.

Sarkar M, Harsch CK, Matic GT, Hoffman K, Norris JR 3rd, Otto TC, Lenz DE, Cerasoli DM, Magliery TJ.

J Lipids. 2012;2012:610937. doi: 10.1155/2012/610937. Epub 2012 Jun 7.

2.

Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.

Rochu D, Chabrière E, Masson P.

Toxicology. 2007 Apr 20;233(1-3):47-59. Epub 2006 Sep 3. Review.

PMID:
17007987
3.

Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity.

Valiyaveettil M, Alamneh YA, Doctor BP, Nambiar MP.

Toxicol Lett. 2012 Apr 5;210(1):87-94. doi: 10.1016/j.toxlet.2012.01.013. Epub 2012 Jan 25. Review.

PMID:
22301377
4.

Stabilization of the active form(s) of human paraoxonase by human phosphate-binding protein.

Rochu D, Chabrière E, Renault F, Elias M, Cléry-Barraud C, Masson P.

Biochem Soc Trans. 2007 Dec;35(Pt 6):1616-20. Review.

PMID:
18031277
5.

[Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity].

Josse D, Masson P.

Ann Pharm Fr. 2001 Apr;59(2):108-18. Review. French.

PMID:
11320335
6.

Human serum paraoxonase.

Mackness B, Durrington PN, Mackness MI.

Gen Pharmacol. 1998 Sep;31(3):329-36. Review.

PMID:
9703197
7.

Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates.

Costa LG, Cole TB, Furlong CE.

J Toxicol Clin Toxicol. 2003;41(1):37-45. Review.

PMID:
12645966
8.

Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.

Furlong CE.

J Biochem Mol Toxicol. 2007;21(4):197-205. Review. Erratum in: J Biochem Mol Toxicol. 2007;21(5):323.

PMID:
17936934
9.

Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.

Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM.

Toxicology. 2007 Apr 20;233(1-3):31-9. Epub 2006 Dec 1. Review.

PMID:
17188793
10.

Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.

Costa LG, Cole TB, Vitalone A, Furlong CE.

Clin Chim Acta. 2005 Feb;352(1-2):37-47. Review.

PMID:
15653099
11.

The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.

James RW, Deakin SP.

Free Radic Biol Med. 2004 Dec 15;37(12):1986-94. Review.

PMID:
15544917
12.

Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.

Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE.

Biomarkers. 2003 Jan-Feb;8(1):1-12. Review.

PMID:
12519632
13.

Genetic polymorphism in paraoxonase 1 (PON1): Population distribution of PON1 activity.

Ginsberg G, Neafsey P, Hattis D, Guyton KZ, Johns DO, Sonawane B.

J Toxicol Environ Health B Crit Rev. 2009;12(5-6):473-507. doi: 10.1080/10937400903158409. Review.

PMID:
20183530
14.

Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).

Furlong CE, Li WF, Richter RJ, Shih DM, Lusis AJ, Alleva E, Costa LG.

Neurotoxicology. 2000 Feb-Apr;21(1-2):91-100. Review.

PMID:
10794389
15.

Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants.

Furlong CE, Cole TB, Jarvik GP, Pettan-Brewer C, Geiss GK, Richter RJ, Shih DM, Tward AD, Lusis AJ, Costa LG.

Neurotoxicology. 2005 Aug;26(4):651-9. Review.

PMID:
16112327
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk